Skip to content
FDA drug shortage status

Is Sodium Acetate Injection in shortage?

Yes. Sodium Acetate Injection is on FDA’s drug shortage list (unavailable), last updated Nov 15, 2026.

In shortageFDA status
15packages listed
1unavailable

Why it’s in shortage

  • Other

Every listed package

FDA tracks shortages per package. What each maker reports, most recently updated first:

  • Sodium Acetate, Injection, 40 mEq/20mL (2 mEq/mL) (NDC 71357-002-10)
    Milla PharmaceuticalsIn shortageAvailableUpdated Nov 15, 2026

    Maker contact: 833-251-8463

  • Sodium Acetate, Injection, 100 mEq/50mL (2 mEq/mL) (NDC 71357-007-10)
    Milla PharmaceuticalsIn shortageAvailableUpdated Nov 15, 2026

    Maker contact: 833-251-8463

  • Sodium Acetate, Injection, 200 mEq/100mL (2 mEq/mL) (NDC 71357-008-10)
    Milla PharmaceuticalsIn shortageAvailableUpdated Nov 15, 2026

    Maker contact: 833-251-8463

  • Sodium Acetate, Injection, 400 mEq/100mL (4 mEq/mL) (NDC 71357-009-10)
    Milla PharmaceuticalsIn shortageLimited AvailabilityUpdated Nov 15, 2026

    Estimated recovery: TBD

    Maker contact: 833-251-8463

  • Sodium Acetate, Injection, 100 mEq/50 mL (2 mEq/mL) (NDC 0409-3299-05)
    Hospira, Inc., a Pfizer CompanyIn shortageAvailableUpdated Nov 9, 2026

    Maker contact: 844-646-4398

  • Sodium Acetate, Injection, 200 mEq/100 mL (2 mEq/mL) (NDC 0409-3299-06)
    Hospira, Inc., a Pfizer CompanyIn shortageAvailableUpdated Nov 9, 2026

    Maker contact: 844-646-4398

  • Sodium Acetate, Injection, 200 mEq/100 mL (2 mEq/mL) (NDC 0409-3299-25)
    Hospira, Inc., a Pfizer CompanyIn shortageAvailableUpdated Nov 9, 2026

    Maker contact: 844-646-4398

  • Sodium Acetate, Injection, 100 mEq/50 mL (2 mEq/mL) (NDC 0409-3299-26)
    Hospira, Inc., a Pfizer CompanyIn shortageAvailableUpdated Nov 9, 2026

    Maker contact: 844-646-4398

  • Sodium Acetate, Injection, 40 mEq/20 mL (2 mEq/mL) (NDC 0409-7299-25)
    Hospira, Inc., a Pfizer CompanyIn shortageAvailableUpdated Nov 9, 2026

    Maker contact: 844-646-4398

  • Sodium Acetate, Injection, 40 mEq/20 mL (2 mEq/mL) (NDC 0409-7299-73)
    Hospira, Inc., a Pfizer CompanyIn shortageAvailableUpdated Nov 9, 2026

    Maker contact: 844-646-4398

  • Sodium Acetate, Injection, 4 meq/100 mL (NDC 63323-032-00)
    Fresenius Kabi USA, LLCIn shortageUnavailableUpdated Nov 3, 2026

    Next release November 2026. Check wholesalers for inventory.

    Maker contact: 888-386-1300

  • Sodium Acetate, Injection, 164 mg/1 mL (NDC 70069-047-25)
    Somerset Therapeutics, LLCIn shortageAvailableUpdated Oct 27, 2026

    Maker contact: 732-554-1037

  • Sodium Acetate, Injection, 164 mg/1 mL (NDC 70069-048-20)
    Somerset Therapeutics, LLCIn shortageAvailableUpdated Oct 27, 2026

    Maker contact: 732-554-1037

  • Sodium Acetate, Injection, 40 mEq/20mL (2 mEq/mL) (NDC 0641-6261-01)
    Hikma Pharmaceuticals USA, Inc.In shortageAvailableUpdated Oct 14, 2026

    Additional lots will be available. Product will be made available as it is released.

    Maker contact: 800-631-2174

  • Sodium Acetate, Injection, 100 mEq/50mL (2 mEq/mL) (NDC 0641-6262-01)
    Hikma Pharmaceuticals USA, Inc.In shortageAvailableUpdated Oct 14, 2026

    Additional lots will be available. Product will be made available as it is released.

    Maker contact: 800-631-2174

Sodium Acetate Injection shortage questions

Is Sodium Acetate Injection in shortage?

Yes. Sodium Acetate Injection is on FDA’s drug shortage list (unavailable), last updated Nov 15, 2026.

Why is there a Sodium Acetate Injection shortage?

FDA records the reason as: Other.

What should I do if I can’t get Sodium Acetate Injection?

Don’t stop or ration it on your own. Ask your pharmacist whether another strength, package size or maker is in stock, and ask your prescriber about an alternative if none is.

Source: FDA Drug Shortages Database via openFDA. FDA notes that openFDA data is unvalidated and should not be used to make decisions about medical care; ask your pharmacist or prescriber before changing any medication. FDA Drug Shortages Database.